Cite
MLA Citation
S.M. Gadgeel et al.. “Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders.” European journal of cancer, vol. 72, n.d., pp. S185–. http://access.bl.uk/ark:/81055/vdc_100041522304.0x00005b